The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy

被引:18
作者
Xu, Liping [1 ,2 ]
Xie, Xiaoli [2 ]
Luo, Ying [1 ,3 ]
机构
[1] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Yunnan, Peoples R China
[2] Kunming Univ Sci & Technol, Med Sch, Kunming 650500, Yunnan, Peoples R China
[3] Guizhou Med Univ, Sch Basic Med, Guizhou Prov Key Lab & Drug Dev Common Dis, Guiyang, Guizhou, Peoples R China
基金
美国国家科学基金会;
关键词
Tumour; TME; TAM transformation; Immunotherapy; HYPOXIA-INDUCIBLE FACTORS; EXPRESSING MESOTHELIN CRS-207; CELL LUNG-CANCER; ALTERNATIVE ACTIVATION; PHASE-I; ANTIBODY CP-870,893; INHIBITION ALTERS; GASTRIC-CANCER; POLARIZATION; M2;
D O I
10.1016/j.ejcb.2021.151153
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumour-associated macrophages (TAMs) that present abundantly in the tumour microenvironment (TME) exhibit a protumour property, such as promoting genetic instability, tumour metastasis and immunosuppression. Macrophage-targeted therapeutic approaches hence have been applied and shown their significances in the process of tumour immune treatment, including blocking TAM recruitment, depleting or transforming TAMs that already exist in the tumour site. Here, we summarized the functional regulation of TAMs in the respects of hypoxia environment, metabolism in the tumour microenvironment and the transcription factors involved. We reviewed the strategies for transforming TAMs, including immune stimuli targeting TAMs, inhibitors against TAMs, pathogen or irradiation stimulation on TAMs, and the application of natural compounds in TAMs. Furthermore, we also discussed the macrophage-targeted therapies in the clinical studies. Taken together, this review tries to shed light on the TAM regulation and the main strategies of TAM reprogramming for an enhanced immune surveillance.
引用
收藏
页数:14
相关论文
共 50 条
[21]   CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment [J].
Lu, Tingwei ;
Zhang, Zhen ;
Zhang, Jianjun ;
Pan, Xinhua ;
Zhu, Xueqin ;
Wang, Xu ;
Li, Zhihui ;
Ruan, Min ;
Li, Huasheng ;
Chen, Wantao ;
Yan, Ming .
JOURNAL OF EXTRACELLULAR VESICLES, 2022, 11 (05)
[22]   Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming [J].
Guo, Rongqi ;
Wang, Rui ;
Zhang, Weisong ;
Li, Yangyang ;
Wang, Yihao ;
Wang, Hao ;
Li, Xia ;
Song, Jianxiang .
CANCER CONTROL, 2025, 32
[23]   Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer [J].
Honkanen, Tiia J. ;
Tikkanen, Antti ;
Karihtala, Peeter ;
Makinen, Markus ;
Vayrynen, Juha P. ;
Koivunen, Jussi P. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[24]   Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development [J].
Hashimoto, Okito ;
Yoshida, Makiko ;
Koma, Yu-Ichiro ;
Yanai, Tomoko ;
Hasegawa, Daiichiro ;
Kosaka, Yoshiyuki ;
Nishimura, Noriyuki ;
Yokozaki, Hiroshi .
JOURNAL OF PATHOLOGY, 2016, 240 (02) :211-223
[25]   Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge [J].
Marzano Rodrigues Petruzzi, Maria Noel ;
Cherubini, Karen ;
Salum, Fernanda Goncalves ;
Zancanaro de Figueiredo, Maria Antonia .
DIAGNOSTIC PATHOLOGY, 2017, 12
[26]   GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity [J].
Ruffolo, Luis, I ;
Jackson, Katherine M. ;
Kuhlers, Peyton C. ;
Dale, Benjamin S. ;
Guilliani, Nathania M. Figueroa ;
Ullman, Nicholas A. ;
Burchard, Paul R. ;
Qin, Shuyang S. ;
Juviler, Peter G. ;
Keilson, Jessica Millian ;
Morrison, Ashley B. ;
Georger, Mary ;
Jewell, Rachel ;
Calvi, Laura M. ;
Nywening, Timothy M. ;
O'Dell, Michael R. ;
Hezel, Aram F. ;
De Las Casas, Luis ;
Lesinski, Gregory B. ;
Yeh, Jen Jen ;
Hernandez-Alejandro, Roberto ;
Belt, Brian A. ;
Linehan, David C. .
GUT, 2022, 71 (07) :1386-1398
[27]   Targeting MS4A4A on tumour-associated macrophages restores CD8+T-cell-mediated antitumour immunity [J].
Li, Yongsheng ;
Shen, Zhiyong ;
Chai, Zhen ;
Zhan, Yizhi ;
Zhang, Yaowei ;
Liu, Zhengyu ;
Liu, Yuechen ;
Li, Zhenkang ;
Lin, Mingdao ;
Zhang, Zhanqiao ;
Liu, Wei ;
Guan, Shenyuan ;
Zhang, Jinchao ;
Qian, Junying ;
Ding, Yi ;
Li, Guoxin ;
Fang, Yuan ;
Deng, Haijun .
GUT, 2023, 72 (12) :2307-+
[28]   Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy [J].
Helal, Israa M. ;
Kamal, Monica A. ;
Abd El-Aziz, Mostafa K. ;
El Tayebi, Hend M. .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2024, 26
[29]   Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in an In Vitro Model of Tumour-Associated Macrophages [J].
Al-Fityan, Salma ;
Diesel, Britta ;
Fischer, Thorben ;
Ampofo, Emmanuel ;
Schomisch, Annika ;
Mashayekhi, Vida ;
Schneider, Marc ;
Kiemer, Alexandra K. .
PHARMACEUTICS, 2023, 15 (07)
[30]   Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review [J].
Yuan, Weichen ;
Zhang, Jiexiang ;
Chen, Haibin ;
Zhuang, Yupei ;
Zhou, Hongli ;
Li, Wenting ;
Qiu, Wenli ;
Zhou, Hongguang .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (11)